Trial intelligence / Profile preview

VASCEPA-COVID-19

NCT04412018Phase 2Completed

Sponsor
Canadian Medical and Surgical Knowledge Translation Research Group
Start
Jun 2020
Primary completion
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of omega-3-acid triglycerides in coronavirus disease 2019 (COVID-19), sponsored by Canadian Medical and Surgical Knowledge Translation Research Group. Started Jun 2020; status: completed.

02

Drugs

omega-3-acid triglycerides
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04412018.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04412018.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call